**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: February 12, 1975
* Date of Admission: March 10, 2023
* Date of Discharge: March 17, 2023

**Chief Complaint and Reason for Admission:**

John Doe, a 48-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of increasing thirst and frequent urination over the past three months. He was referred to our hospital by his primary care physician for further evaluation and management of his suspected type 2 diabetes.

**Medical History:**

* The patient has a significant family history of type 2 diabetes, with his mother and two siblings being diagnosed with the condition in their 40s and 50s.
* He has no significant medical history, except for occasional high blood pressure readings in the past.
* He has been a non-smoker for the past 10 years and has a moderate exercise routine.

**Physical Examination and Laboratory Results:**

* On admission, the patient's physical examination was normal, with no signs of diabetic complications.
* Laboratory results revealed:
	+ Fasting plasma glucose (FPG) level: 220 mg/dL
	+ Glycosylated hemoglobin (HbA1C) level: 7.5%
	+ Random glucose value: 250 mg/dL
	+ Complete blood count (CBC), electrolyte panel, and renal function tests were normal.

**Diagnostic Evaluation:**

Based on the patient's symptoms, physical examination, and laboratory results, a diagnosis of type 2 diabetes was made.

**Treatment and Management:**

* The patient was started on metformin 500 mg twice daily, with instructions to increase the dose to 1000 mg twice daily if necessary.
* He was also prescribed glipizide 10 mg twice daily as secondary therapy.
* The patient was educated on the importance of diet, exercise, and medication compliance to manage his blood sugar levels.
* He was advised to follow a Mediterranean-style diet, focusing on whole foods, high-quality carbohydrates, and moderate protein and fat intake.
* The patient was also encouraged to engage in at least 150 minutes of moderate-intensity exercise per week, with adjustments made for hypoglycemia risk.

**Medications and Dosing:**

* Metformin 500 mg twice daily (increased to 1000 mg twice daily as needed)
* Glipizide 10 mg twice daily

**Education and Counseling:**

The patient received detailed education on the causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications. He was instructed to monitor his blood glucose levels regularly and adjust his insulin doses based on carbohydrate intake. The patient was also advised to report any signs of hypoglycemia or hyperglycemia to his healthcare provider immediately.

**Follow-up and Monitoring:**

The patient was scheduled for a follow-up appointment with his primary care physician in one week to review his blood sugar control and adjust his medication regimen as needed.

**Preventive Care:**

The patient was vaccinated against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2 as recommended.

**Discharge Instructions:**

The patient was discharged with a prescription for metformin and glipizide, as well as instructions to follow up with his primary care physician in one week. He was advised to continue his Mediterranean-style diet and exercise routine, and to report any signs of hypoglycemia or hyperglycemia to his healthcare provider immediately.

**Special Instructions:**

The patient was instructed to follow up with his primary care physician for regular monitoring of his blood sugar control, and to report any changes in his symptoms or physical examination findings.

The patient was also advised to schedule regular professional podiatric care to monitor for any signs of diabetic foot complications.